Insider Trading
Filed: 2026-03-16
Key Insights
- The reporting person, James R. Neal, acquired pre-funded warrants and accompanying warrants to purchase up to 4,946 American Depositary Shares (ADSs) of Akari Therapeutics Plc on December 16, 2025 in a private placement transaction.
- The reporting person also acquired pre-funded warrants and warrants to purchase up to 6,186 ADSs in exchange for cancellation of an outstanding promissory note held by the reporting person.
- All of the acquired warrants and pre-funded warrants are subject to shareholder approval and have five-year terms or are exercisable until fully exercised.